期刊文献+

心房颤动的药物治疗 被引量:2

下载PDF
导出
摘要 心房颤动是常见且难治疗和难控制的心律失常,治疗方法包括药物、电复律以及射频消融等。传统的抗心律失常药物存在增加导致室性心律失常的风险,不利于急性房颤的转复以及长期预防,新的治疗房颤药物如维那卡兰、决奈达隆、雷诺嗪等在作用机制、药效动力学、药代动力学等方面与其他抗心律失常药物相比,有着各自的特殊性及优越性,不仅能有效转复房颤并控制其复发,同时不存在非可逆性不良反应,且尖端扭转型室速及其他恶性心律失常等不良反应亦极其罕见。
作者 邓雨晴 方宏
出处 《国际心血管病杂志》 2011年第4期217-219,共3页 International Journal of Cardiovascular Disease
  • 相关文献

参考文献29

  • 1Orth PM, Hesketh JC, Mak CK, et al. RSD1235 blocks late INa and suppresses early afterdepolarizations and TdP induced by class Ⅲ agents[J]. Cardiovasc Res, 2006, 70(3) :486-496.
  • 2[No authors listed]. Vernakalant: RSD 1235, RSD-1235, RSD1235[J]. DrugsRD, 2007,8(4):259-265.
  • 3Mao ZL, Wheeler JJ, Clohs L, et al. Pharmacokinetics of novel atrial-selective antiarrhythmic agent vernakalant hydrochloride injection (RSD1235); Influence of CYP2D6 expression and other factors [J]. J Clin Pharmacol, 2009, 49(1) :17-29.
  • 4Roy D, Rowe BH, Steill IG, et al. A randomized controlled trial of RSD 1235, a novel antiarrhythmic agent, in the treatment of recent onset atrial brillation[J]. J Am Coil Cardiol, 2004, 44(12):2355-2361.
  • 5Roy D, Pratt CM, Torp-Pedersen C, et al. Vernakalant hydrochloride for rapid cardioversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial [ J ]. Circulation, 20(18, 117(12): 1518-1525.
  • 6KoweyPR, Dorian P, MitchellLB, et al, Vernakalant hydrocholoride for the rapid conversion of atrial ? brillation after cardiac surgery: a randomized, double-blind, placebo- controlled trial [J]. Circ Arrhythm Electrophysiol, 2009, 2(6) : 652- 659.
  • 7Cialdella P, Pedicina D, Santangeli P. Novel agents for the acute conversion of atrial fibrillation: focus on vernakalant [J]. Recent Pat Cardiovasc Drug Discov, 2011,6(1) : 1-8.
  • 8Stiell IG, Roos JS, Kavanagh KM, et al. Amulticenter, open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm[JJ. Am Heart J, 2010,159(6) : 1095-1101.
  • 9Galve E, Rius T, Ballester R, et al. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study[J].J Am Coll Cardiol, 1996, 27(5) : 1079-1082.
  • 10Vardas PE, Kochiadakis GE, Igoumenidis NE, et al. Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study[J]. Chest, 2000, 117(6) :1538-1545.

同被引文献10

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部